Providers: Understanding the Organizations That Shape Adoption

Entrepreneurs entering the medical technology space often begin with an idea—an elegant mechanism, a clever algorithm, or a new way to diagnose or treat disease. But innovation alone doesn’t guarantee impact. A device only becomes meaningful when it aligns with the needs, motivations, and constraints of the people who will use it or be affected by it.

This five-part series is designed for founders and early-stage teams who want to expand their understanding of their market landscape through the lens of the Five Ps: Patients, Physicians (clinicians), Providers (facilities and organizations), Payers (insurance companies), and Policy Makers. Each article explores one stakeholder group, discussing the dynamics that shape their decisions and the unmet needs that should guide your product development.

In this third article, we turn to Providers—the organizations that drive the market through their service offerings on a day-to-day basis.

The Healthcare Institution

If physicians are the hands that use medical technology, providers—the hospitals, clinics, and care centers—are the environments that determine whether that technology can thrive. These institutions are complex ecosystems with their own priorities, constraints, and internal politics. Understanding them is essential for any entrepreneur hoping to see their product widely adopted.

Providers vary widely in structure and mission. A large academic medical center operates differently from a community hospital, which operates differently from an ambulatory surgery center or a primary care clinic. Some are part of sprawling Integrated Delivery Networks (IDNs) or Accountable Care Organizations (ACOs), where decisions are centralized and cost structures are tightly managed. Others operate independently, with more flexibility but fewer resources. 

These differences shape how new technologies are evaluated. A for-profit hospital may prioritize efficiency and revenue generation, while a nonprofit may focus on community benefit or long-term outcomes. Leadership backgrounds matter too: administrators with clinical experience may evaluate a device differently from those with business or finance backgrounds.

Financial dynamics are central to provider decision-making. Some procedures are reimbursed as bundled payments, meaning the hospital receives a fixed amount regardless of the products used. In these cases, a device that increases costs—even slightly—may be a hard sell. Other procedures are reimbursed item-by-item, giving providers more flexibility to adopt new tools. Understanding these payment structures can help you position your product more effectively.

Operational realities also play a major role. A device may be clinically superior, but if it requires additional staff, disrupts workflow, or introduces new sources of frustration, adoption may stall. In one example, a diagnostic test we studied was considered the best available but was underused by clinics simply because accessing the results was cumbersome. When another company introduced an online portal that streamlined data access, usage increased dramatically for the competition. The barrier wasn’t clinical; it was logistical.

Providers’ unmet needs often revolve around efficiency, cost control, and ease of integration. They want technologies that reduce bottlenecks, shorten procedures, minimize training requirements, and align with existing systems. They also want predictability: predictable costs, predictable outcomes, and predictable workflows.

For entrepreneurs, the key is to understand the provider not as a building, but as a living system. Walk the halls, observe the flow of patients and staff, and listen to the frustrations that surface in everyday conversations. When you design with these realities in mind, your product becomes not just clinically valuable, but operationally indispensable.

A Word from Webeck

Hospitals and care systems adopt technologies that strengthen operations, not complicate them. Even the most elegant device will stall if it disrupts staffing or throughput. Winning inside provider organizations requires understanding their incentives, their constraints, and the invisible mechanisms that keep a clinical environment running.

MORE FROM THIS AUTHOR—Physicians: Designing for the Clinicians Who Bring Your Technology to Life

Ilsa Webeck has more than 30 years of experience assessing commercial and market viability in the medtech space. At Simbex, a design, development, and commercialization firm, she works with companies of all sizes in support of the commercialization pathway, performing primary and secondary research to uncover unmet needs, establishing value propositions, and supporting development of regulatory, reimbursement, and quality strategies. Prior to Simbex, Webeck founded MedTech Strategies, where she worked with a wide range of medtech organizations focused on assessing commercial fit and establishing a path to commercial success. Her previous experiences include group product director at J&J’s DePuy Spine, leading the strategic marketing efforts and upstream marketing team, and associate director for global commercial strategy in the MS Franchise at Biogen Idec.